Efficacy of oral BCG vaccination in protecting free-ranging cattle from natural infection by Mycobacterium bovis.

Autor: Nugent G; Landcare Research - Manaaki Whenua, PO Box 40, Lincoln, 7640, New Zealand. Electronic address: nugentg@landcareresearch.co.nz., Yockney IJ; Landcare Research - Manaaki Whenua, PO Box 40, Lincoln, 7640, New Zealand., Whitford J; Landcare Research - Manaaki Whenua, PO Box 40, Lincoln, 7640, New Zealand., Aldwell FE; Centre for Innovation, University of Otago, Dunedin, New Zealand., Buddle BM; AgResearch, Hopkirk Research Institute, Palmerston North, New Zealand.
Jazyk: angličtina
Zdroj: Veterinary microbiology [Vet Microbiol] 2017 Sep; Vol. 208, pp. 181-189. Date of Electronic Publication: 2017 Aug 09.
DOI: 10.1016/j.vetmic.2017.07.029
Abstrakt: Vaccination of cattle against bovine tuberculosis could be a valuable control strategy, particularly in countries faced with intractable ongoing infection from a disease reservoir in wildlife. A field vaccination trial was undertaken in New Zealand. The trial included 1286 effectively free-ranging cattle stocked at low densities in a remote 7600ha area, with 55% of them vaccinated using Mycobacterium bovis BCG (Danish strain 1311). Vaccine was administered orally in all but 34 cases (where it was injected). After inclusion, cattle were exposed to natural sources of M. bovis infection in cattle and wildlife, most notably the brushtail possum (Trichosurus vulpecula). Cattle were slaughtered at 3-5 years of age and were inspected for tuberculous lesions, with mycobacteriological culture of key tissues from almost all animals. The prevalence of M. bovis infection was 4.8% among oral BCG vaccinates, significantly lower than the 11.9% in non-vaccinates. Vaccination appeared to both reduce the incidence of detectable infection, and to slow disease progression. Based on apparent annual incidence, the protective efficacy of oral BCG vaccine was 67.4% for preventing infection, and was higher in cattle slaughtered soon after vaccination. Skin-test reactivity to tuberculin was high in vaccinates re-tested 70days after vaccination but not in non-vaccinates, although reactor animals had minimal response in gamma-interferon blood tests. In re- tests conducted more than 12 months after vaccination, skin-test reactivity among vaccinates was much lower. These results indicate that oral BCG vaccination could be an effective tool for greatly reducing detectable infection in cattle.
(Copyright © 2017 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: